Activity Provided By:

Jointly Provided by AKH, Inc. and peerXchange, Inc

Diseases Associated with Pulmonary Fibrosis: What Do We Currently Know?

Overview / Abstract:	Fibrotic processes occur in many diseases. Advances in genetic, molecular, and cellular research are hinting at the pathophysiology behind their development and options for new therapeutic interventions and strategies. In this podcast, Dr. Zibrak reviews what is currently known about fibrosis in interstitial lung disease and current thinking relative to the role of antifibrotic therapy in patients with IPF and SSc-ILD. What type of diseases lead to, or have a complication of pulmonary fibrosis? Are there well-studied diseases in which fibrotic pathologies have been well-described? What is the current thinking relative to the role of antifibrotic therapy in patients with IPF and SSc-ILD? Learning Objectives Upon completion of this activity, participants should be better able to: Describe the diseases associated with pulmonary fibrosis. Explain the current understanding of the pathophysiological processes leading to the development of fibrosis. Review current evidence supporting the use of antifibrotic therapy in patients with IPF.
Expiration	Aug 26, 2020
Discipline(s)	Nurse Practitioner , Physician CME, Physician Assistant CME
Format	Podcast
Credits / Hours	.5
Accreditation	ACCME
Presenters / Authors / Faculty	Faculty Joseph D. Zibrak, MD Associate Professor of Medicine Harvard Medical School Director, ILD Center Division of Pulmonology and Critical Care Beth Israel Deaconess Medical Center Boston, MA Lesley Anne Saketkoo, MD, MPH Associate Professor of Medicine Tulane University School of Medicine Clinical Immunology, Allergy and Rheumatology, Pulmonary Diseases, Critical Care and Environmental Medicine Director, New Orleans Scleroderma & Sarcoidosis Patient Care & Research Center Co-Director, UMC Comprehensive Pulmonary Hypertension Center New Orleans, LA
Sponsors / Supporters / Grant Providers	Boehringer Ingelheim Pharmaceuticals, Inc.
Keywords / Search Terms	Relias LLC idiopathic pulmonary fibrosis, ipf systemic sclerosis-interstitial lung disease, ild, lung disease Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map